Open Medicine (Jun 2018)

MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease

  • Kobusiak-Prokopowicz Malgorzata,
  • Krzysztofik Justyna,
  • Kaaz Konrad,
  • Jolda-Mydlowska Beata,
  • Mysiak Andrzej

DOI
https://doi.org/10.1515/med-2018-0037
Journal volume & issue
Vol. 13, no. 1
pp. 237 – 246

Abstract

Read online

The aim of the study was to assess MMP-2 (matrix metalloproteinase-2) and TIMP-2 (tissue inhibitor of metalloproteinase-2) serum levels in patients with diverse types of heart failure (HF) and chronic kidney disease (CKD).

Keywords